Cutaneous Safety Profile of Nemolizumab in Moderate‑to‑Severe Atopic Dermatitis and Prurigo Nodularis: Pooled Analysis of Phase 3 Trials (ARCADIA 1&2 and OLYMPIA 1&2) Nodularis: Pooled Analysis of Phase 3 Trials (ARCADIA 1&2 and OLYMPIA 1&2). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s748, 2026. DOI: 10.25251/yghmqq47. Disponível em: https://skin.dermsquared.com/skin/article/view/4121. Acesso em: 2 may. 2026.